• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON ENDO-SURGERY, LLC.; STAPLE, IMPLANTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON ENDO-SURGERY, LLC.; STAPLE, IMPLANTABLE Back to Search Results
Catalog Number GLC80
Medical Device Problem Codes Adverse Event Without Identified Device or Use Problem (2993); Patient Device Interaction Problem (4001)
Health Effect - Clinical Codes Failure to Anastomose (1028); Hemorrhage/Blood Loss/Bleeding (1888); Obstruction/Occlusion (2422)
Date of Event 10/16/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).Date sent: 4/8/2026.D4: batch # unk.D4: udi: as the lot number for the device involved in the event was not provided, the full udi is currently not available.D4: udi: the expiration date is currently not available.Therefore, the full udi is currently not available.This report is related to a journal article; therefore, no product will be returned for analysis and the batch history records cannot be reviewed as the lot/batch number has not been provided.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Does the author/surgeon believe that the ethicon devices mentioned in this article caused/contributed to the reported events in the article? this report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Event or Problem Description
This complaint is from a literature source.The following literature cite has been reviewed: benshabat e, yuval jb, leibovitzh h, hirsch a, lahat g, kariv y, zemel m.Comparing perioperative outcomes of stapled versus handsewn kono-s anastomosis after ileocolonic resection for crohn's disease.Tech coloproctol.2025 oct 16;29(1):182.Doi: 10.1007/s10151-025-03219-y.Pmid: 41099860; pmcid: pmc12532619.The aim of the study is to compare the operative time and perio perative outcomes of stapled versus handsewn kono-s ileocolonic anastomosis in patients with cd.This was a single-center, observational cohort study.The study included all consecutive patients with a confirmed diagnosis of cd, who underwent an antimesenteric functional end-to-end kono-s anastomosis for restoring bowel continuity after icr at the tel aviv medical center from 11 july 2023 to 3 april 2025.25 patients underwent ileocolic resection with an antimesenteric functional end-to-end (kono-s) anastomosis.In total, 10 patients (40%) had a stapled kono-s anastomosis and 15 (60%) had a handsewn kono-s.The handsewn anastomosis was done as described in previous studies [6], whereas the stapled kono-s anastomosis was done with the same principles while using a gia¿ or echelon linear cutter¿ with 80 mm length, 3.8/1.5 mm (open/close) staples and 3.7/1.5 mm (open/close), respectively.¿ reported complications include: echelon linear cutter¿ (ees).Anastomotic leak (n=2).Treatment: treated with antibiotics.Post operative ileus (n=1) treatment: not reported.Postoperative intraluminal hemorrhage (n=2).Treatment: one patient required re admission, but none required transfusion.In conclusion, converting the functional end-to-end ileocolic anastomosis kono-s from handsewn to a stapled technique significantly reduces the operative time while lowering post operative crp levels and without compromising 30-day peri-operative outcomes.We believe that this allows standardization of the technique and shows feasibility and safety of the procedure.Further studies are needed to show advantages in endoscopic, clinical, and surgical recurrences.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Common Device Name
STAPLE, IMPLANTABLE
Manufacturer (Section D)
ETHICON ENDO-SURGERY, LLC.
475 calle c
guaynabo 00969
*  00969
Manufacturer Contact
orla o'mahony
475 calle c
guaynabo 
*  
3035526892
MDR Report Key24822272
Report Number3005075853-2026-02659
Device Sequence Number9686679
Product Code GDW
UDI-Device Identifier10705036030881
UDI-Public10705036030881
Combination Product (Y/N)N
Initial Reporter CountryIS
PMA/510(K) Number
K223760
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Literature
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 04/08/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberGLC80
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 03/25/2026
Initial Report FDA Received Date04/08/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-